| WGS Genedx Holdings Corp. | 24.29% | 3,007,164 | $391.1M | No change |
| RVMD Revolution Medicines Inc. | 12.75% | 2,577,333 | $205.3M | Reduce -2.6% |
| BLFS Biolife Solutions Inc. | 8.95% | 5,957,165 | $144.0M | Reduce -11.2% |
| LAB Standard Biotools Inc. | 7.06% | 88,783,856 | $113.6M | Add +14.5% |
| RLAY Relay Therapeutics Inc. | 6.83% | 13,003,574 | $110.0M | Add +14.7% |
| GPCR Structure Therapeutics Inc. | 5.08% | 1,175,000 | $81.7M | Reduce -24.4% |
| ILMN Illumina Inc. | 4.89% | 600,000 | $78.7M | Add +14.3% |
| RNAM Avidity Biosciences Inc. | 4.48% | 1,000,000 | $72.1M | Reduce -43.8% |
| BEAM Beam Therapeutics Inc. | 2.75% | 1,600,000 | $44.4M | No change |
| GH Guardant Health Inc. | 2.41% | 380,000 | $38.8M | Add +280.0% |
| MAZE Maze Therapeutics Inc. | 1.95% | 758,857 | $31.4M | No change |
| DNLI Denali Therapeutics Inc. | 1.89% | 1,840,000 | $30.4M | Add +106.7% |
| ALNY Alnylam Pharmaceuticals Inc. | 1.85% | 75,000 | $29.8M | Add +36.4% |
| NGNE Neurogene Inc. | 1.66% | 1,295,361 | $26.7M | No change |
| TXG 10X Genomics Inc. Class A | 1.42% | 1,400,000 | $22.8M | New |
| SPRY Ars Pharmaceuticals Inc. | 1.16% | 1,600,000 | $18.6M | No change |
| TEM Tempus AI Inc. Class A | 1.08% | 294,127 | $17.4M | No change |
| UNH Unitedhealth Group Inc. | 1.03% | 50,000 | $16.5M | Add +100.0% |
| SEPN Septerna Inc. | 0.96% | 553,268 | $15.4M | No change |
| HIMS Hims & Hers Health Inc. | 0.78% | 385,000 | $12.5M | Add +67.4% |
| VCYT Veracyte Inc. | 0.72% | 276,308 | $11.6M | No change |
| DXCM Dexcom Inc. | 0.72% | 175,000 | $11.6M | New |
| SRRK Scholar Rock Holding Corp. | 0.71% | 260,000 | $11.5M | New |
| CI The Cigna Group | 0.68% | 40,000 | $11.0M | New |
| PRME Prime Medicine Inc. | 0.68% | 3,167,175 | $11.0M | No change |
| INCY Incyte Corp. | 0.61% | 100,000 | $9.9M | No change |
| DGX Quest Diagnostics Inc. | 0.54% | 50,000 | $8.7M | New |
| TSHA Taysha Gene Therapies Inc. | 0.51% | 1,500,000 | $8.3M | New |
| PACB Pacific Biosciences of Calif | 0.49% | 4,223,767 | $7.9M | Add +483.6% |
| LEGN Legend Biotech Corp.-ADR | 0.29% | 215,000 | $4.7M | New |
| BBOT Bridgebio Oncology Therapeut | 0.22% | 282,312 | $3.5M | No change |
| ABSI Absci Corp. | 0.21% | 973,260 | $3.4M | No change |
| CTNM Contineum Therapeutics Inc. Class A | 0.11% | 148,333 | $1.7M | No change |
| GLUE Monte Rosa Therapeutics Inc. | 0.08% | 86,014 | $1.3M | No change |
| IPSC Century Therapeutics Inc. | 0.08% | 1,228,190 | $1.2M | No change |
| RXRX Recursion Pharmaceuticals-A | 0.04% | 165,323 | $676K | No change |
| DNA Ginkgo Bioworks Holdings Inc. | 0.02% | 36,493 | $303K | No change |
| TNYA Tenaya Therapeutics Inc. | 0.02% | 361,969 | $258K | No change |